Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence
- PMID: 17921251
- PMCID: PMC2034265
- DOI: 10.1073/pnas.0706778104
Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence
Abstract
Schizophrenia is a complex multifactorial brain disorder with a genetic component. Convergent evidence has implicated oxidative stress and glutathione (GSH) deficits in the pathogenesis of this disease. The aim of the present study was to test whether schizophrenia is associated with a deficit of GSH synthesis. Cultured skin fibroblasts from schizophrenia patients and control subjects were challenged with oxidative stress, and parameters of the rate-limiting enzyme for the GSH synthesis, the glutamate cysteine ligase (GCL), were measured. Stressed cells of patients had a 26% (P = 0.002) decreased GCL activity as compared with controls. This reduction correlated with a 29% (P < 0.001) decreased protein expression of the catalytic GCL subunit (GCLC). Genetic analysis of a trinucleotide repeat (TNR) polymorphism in the GCLC gene showed a significant association with schizophrenia in two independent case-control studies. The most common TNR genotype 7/7 was more frequent in controls [odds ratio (OR) = 0.6, P = 0.003], whereas the rarest TNR genotype 8/8 was three times more frequent in patients (OR = 3.0, P = 0.007). Moreover, subjects with disease-associated genotypes had lower GCLC protein expression (P = 0.017), GCL activity (P = 0.037), and GSH contents (P = 0.004) than subjects with genotypes that were more frequent in controls. Taken together, the study provides genetic and functional evidence that an impaired capacity to synthesize GSH under conditions of oxidative stress is a vulnerability factor for schizophrenia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Skin fibroblast model to study an impaired glutathione synthesis: consequences of a genetic polymorphism on the proteome.Brain Res Bull. 2009 Apr 6;79(1):46-52. doi: 10.1016/j.brainresbull.2008.10.015. Epub 2008 Nov 28. Brain Res Bull. 2009. PMID: 19041695
-
Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.Antioxid Redox Signal. 2011 Oct 1;15(7):2003-10. doi: 10.1089/ars.2010.3463. Epub 2010 Oct 30. Antioxid Redox Signal. 2011. PMID: 20673128
-
Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis.Schizophr Bull. 2016 Sep;42(5):1185-96. doi: 10.1093/schbul/sbw038. Epub 2016 Apr 11. Schizophr Bull. 2016. PMID: 27069063 Free PMC article.
-
Glutathione defense mechanism in liver injury: insights from animal models.Food Chem Toxicol. 2013 Oct;60:38-44. doi: 10.1016/j.fct.2013.07.008. Epub 2013 Jul 12. Food Chem Toxicol. 2013. PMID: 23856494 Free PMC article. Review.
-
Modulating GSH synthesis using glutamate cysteine ligase transgenic and gene-targeted mice.Drug Metab Rev. 2008;40(3):465-77. doi: 10.1080/03602530802186587. Drug Metab Rev. 2008. PMID: 18642143 Review.
Cited by
-
Oxidative stress and glutathione response in tissue cultures from persons with major depression.J Psychiatr Res. 2012 Oct;46(10):1326-32. doi: 10.1016/j.jpsychires.2012.06.008. Epub 2012 Jul 28. J Psychiatr Res. 2012. PMID: 22841833 Free PMC article.
-
Perineuronal nets protect fast-spiking interneurons against oxidative stress.Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5. doi: 10.1073/pnas.1300454110. Epub 2013 May 13. Proc Natl Acad Sci U S A. 2013. PMID: 23671099 Free PMC article.
-
Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration.FASEB J. 2010 Mar;24(3):844-52. doi: 10.1096/fj.09-143974. Epub 2009 Nov 4. FASEB J. 2010. PMID: 19890015 Free PMC article.
-
NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity.Sci Rep. 2018 Jun 22;8(1):9545. doi: 10.1038/s41598-018-27830-2. Sci Rep. 2018. PMID: 29934499 Free PMC article.
-
Echo time optimization for J-difference editing of glutathione at 3T.Magn Reson Med. 2017 Feb;77(2):498-504. doi: 10.1002/mrm.26122. Epub 2016 Feb 25. Magn Reson Med. 2017. PMID: 26918659 Free PMC article.
References
-
- Owen MJ, Craddock N, O'Donovan MC. Trends Genet. 2005;21:518–525. - PubMed
-
- Harrison PJ, Weinberger DR. Mol Psychiatry. 2005;10:40–68. - PubMed
-
- Lewis DA, Levitt P. Annu Rev Neurosci. 2002;25:409–432. - PubMed
-
- Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neuron. 2006;52:139–153. - PubMed
-
- Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F. J Neurochem. 1995;65:2652–2662. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous